FDA Leverages Real-World Data and Partnerships to Accelerate COVID-19 Response
By
Office of the Commissioner
Summary
The FDA and its partners are working to capture real-world data to identify and evaluate innovative approaches for responding to COVID-19 as quickly and safely as possible. The article discusses the agency's efforts to leverage real-world evidence, collaborate with stakeholders, and implement flexible regulatory frameworks to accelerate the development and authorization of medical countermeasures during the pandemic.
Source
bskyFDA Leverages Real-World Data and Partnerships to Accelerate COVID-19 Responsefda.govKey quotes
· 3 pulledFDA and Partners Aim to Capture Real-World Data to Identify Innovative Approaches
Learn about FDA's innovative approaches to respond to COVID-19 as quickly and safely as possible.
Innovation to Respond to COVID-19
You might also wanna read
COVID-19/Coronavirus and Computer Attacks
Microfluidic Assay Quantifies Fibrinaloid Clots in Pediatric Long COVID Patients
This research article presents a study using microfluidic assays to quantify fibrinaloid clots in plasma from pediatric Long COVID patients.
researchsquare.com·8mo ago
A critical review of mRNA vaccine safety and efficacy from mechanistic and public health perspectives
This article provides a critical review of mRNA vaccine safety and efficacy from mechanistic, preclinical, clinical, and public health persp
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
clinicaltrialsabundance.blog·10d agoWhy COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
clinicaltrialsabundance.blog·10d ago
FDA's AI for Drug Approvals Found to Fabricate Studies
The FDA's AI system, designed to expedite drug approvals, has been discovered to generate fake studies and misrepresent research, raising co
The Onion·11mo ago
Moderna's Post-Pandemic Crisis: From Vaccine Success to Corporate Challenges
The article examines Moderna's current crisis despite its success with the COVID-19 vaccine. After achieving a 95% effective vaccine and mas
statnews.com·8mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.